Amedisys Inc
NASDAQ:AMED
Amedisys Inc
Gross Profit
Amedisys Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amedisys Inc
NASDAQ:AMED
|
Gross Profit
$999.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
DaVita Inc
NYSE:DVA
|
Gross Profit
$4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Gross Profit
$3.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
CVS Health Corp
NYSE:CVS
|
Gross Profit
$53.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
8%
|
|
Cigna Corp
NYSE:CI
|
Gross Profit
$25.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Gross Profit
$3.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
See Also
What is Amedisys Inc's Gross Profit?
Gross Profit
999.3m
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Gross Profit amounts to 999.3m USD.
What is Amedisys Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
7%
Over the last year, the Gross Profit growth was 3%. The average annual Gross Profit growth rates for Amedisys Inc have been 2% over the past three years , 7% over the past five years , and 7% over the past ten years .